Celldex Therapeutics, Inc.;University of Iowa Research Foundation
发明人:
Smith, Richard J.H.,Zhang, Yuzhou,Marsh, Henry C.
申请号：
AU2011301996
公开号：
AU2011301996A1
申请日:
2011.09.15
申请国别(地区):
AU
年份:
2013
代理人:
摘要：
A method is disclosed for treating nephropathies involving undesired alternative pathway complement activation by administration of a complement inhibitory protein such as soluble complement receptor type I (sCR1).
